<?xml version="1.0" encoding="UTF-8"?><ns2:project xmlns:ns1="http://gtr.rcuk.ac.uk/gtr/api" xmlns:ns2="http://gtr.rcuk.ac.uk/gtr/api/project" xmlns:ns3="http://gtr.rcuk.ac.uk/gtr/api/fund" xmlns:ns4="http://gtr.rcuk.ac.uk/gtr/api/person" xmlns:ns5="http://gtr.rcuk.ac.uk/gtr/api/project/outcome" xmlns:ns6="http://gtr.rcuk.ac.uk/gtr/api/organisation" ns1:created="2026-06-03T15:52:43Z" ns1:href="http://gtr.ukri.org/gtr/api/projects/E8360F0C-DDBE-41B0-9DD2-320CE2F8EACF" ns1:id="E8360F0C-DDBE-41B0-9DD2-320CE2F8EACF"><ns1:links><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/persons/FEBD57DF-9787-44B5-BCEE-87DBF71C4415" ns1:rel="PM_PER"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/6AD3147C-25BB-44F3-8788-395239A296AC" ns1:rel="LEAD_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/BCEF4DDE-7EBB-4D97-9C5B-9F277C1FEE13" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/6AD3147C-25BB-44F3-8788-395239A296AC" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:end="2024-04-29T23:00:00Z" ns1:href="http://gtr.ukri.org/gtr/api/funds/BC318B25-D0E3-4FE4-A85C-D0FC73506C8D" ns1:rel="FUND" ns1:start="2022-11-01T00:00:00Z"/></ns1:links><ns2:identifiers><ns2:identifier ns2:type="RCUK">10037108</ns2:identifier></ns2:identifiers><ns2:title>Reducing osteoporosis treatment backlog with IBEX Trueview fracture risk prediction software tool on standard plain radiographs</ns2:title><ns2:status>Closed</ns2:status><ns2:grantCategory>Collaborative R&amp;D</ns2:grantCategory><ns2:leadFunder>Innovate UK</ns2:leadFunder><ns2:abstractText>Trueview is an advanced software product that enables bone health diagnoses to be made using standard X-ray scans, rather than the specialised DXA scans currently required.

The technology has been shown to provide accurate diagnosis of osteoporosis on forearm X-rays and this project will further develop the technology to allow it to be used on a wider range of body parts that can be assessed to provide a bone health diagnosis including ankle, pelvis, femur and humerus.

The project will assess the performance of these developments in a human clinical study at the University of Exeter, with the final outputs supporting regulatory certification and ongoing commercialisation and adoption activities.

A successful project will facilitate roll-out and adoption of a product that will have a significant impact on osteoporosis treatment waiting times and will reduce the numbers of fragility fractures incurred, along with their associated health and social care costs.</ns2:abstractText></ns2:project>